Wilbur H. Chen

4.6k total citations
86 papers, 2.9k citations indexed

About

Wilbur H. Chen is a scholar working on Epidemiology, Infectious Diseases and Endocrinology. According to data from OpenAlex, Wilbur H. Chen has authored 86 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 38 papers in Infectious Diseases and 26 papers in Endocrinology. Recurrent topics in Wilbur H. Chen's work include Influenza Virus Research Studies (31 papers), Viral gastroenteritis research and epidemiology (22 papers) and Escherichia coli research studies (21 papers). Wilbur H. Chen is often cited by papers focused on Influenza Virus Research Studies (31 papers), Viral gastroenteritis research and epidemiology (22 papers) and Escherichia coli research studies (21 papers). Wilbur H. Chen collaborates with scholars based in United States, Mali and Switzerland. Wilbur H. Chen's co-authors include Marcelo B. Sztein, Robert L. Atmar, Paul M. Mendelman, Jennifer Ferreira, Robert Edelman, Marcela F. Pasetti, David I. Bernstein, Alan S. Cross, Charles C. Richardson and Myron M. Levine and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Wilbur H. Chen

86 papers receiving 2.8k citations

Peers

Countries citing papers authored by Wilbur H. Chen

Since Specialization

Citations

This map shows the geographic impact of Wilbur H. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilbur H. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilbur H. Chen more than expected).

Fields of papers citing papers by Wilbur H. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilbur H. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilbur H. Chen. The network helps show where Wilbur H. Chen may publish in the future.

Co-authorship network of co-authors of Wilbur H. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Wilbur H. Chen. A scholar is included among the top collaborators of Wilbur H. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilbur H. Chen. Wilbur H. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial 2025 ·The Lancet ·Fatoumata Diallo, Fadima Cheick Haidara, Milagritos D. Tapia, Clara P. Domínguez Islas, Mark R. Alderson, William P. Hausdorff, Lionel Martellet, Nancy Hosken, (unknown), Prasad S. Kulkarni, (unknown), Francesca Vanni, Christine M. Posavad, Samba O. Sow, Karen L. Kotloff, Wilbur H. Chen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
2	New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, October 2024 2024 ·MMWR Morbidity and Mortality Weekly Report ·Sarah Schillie, Jamie Loehr, Wilbur H. Chen, Charlotte A. Moser, Gabrielle Cooper, Cheryl Isenhour, Lucy A. McNamara	8
3	Safety and Tolerability of ShigActive™, a Shigella spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial 2024 ·Antibiotics ·Wilbur H. Chen, Joelle Woolston, (unknown), Courtney K. Robinson, (unknown), Joseph Nkeze, Jasnehta Permala-Booth, Claire M. Fraser, Sharon M. Tennant, (unknown), Marcela F. Pasetti, Yuanyuan Liang, Karen L. Kotloff, Alexander Sulakvelidze, Jennifer A. Schwartz	2
4	Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults 2023 ·Vaccine ·Lisa A. Jackson, Jack T. Stapleton, Emmanuel B. Walter, Wilbur H. Chen, Nadine Rouphael, Evan J. Anderson, Kathleen M. Neuzil, Patricia Winokur, Michael J. Smith, Kenneth E. Schmader, Geeta K. Swamy, (unknown), Mark J. Mulligan, Christina A. Rostad, Kaitlyn Cross, (unknown), (unknown), Paul C. Roberts	2
5	Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study 2023 ·The Lancet Microbe ·Kirsten E. Wiens, Anita Iyer, Taufiqur Rahman Bhuiyan, Lenette L. Lu, Deniz Cizmeci, Matthew J. Gorman, Dansu Yuan, (unknown), Edward T. Ryan, Stephen B. Calderwood, Regina C. LaRocque, Fahima Chowdhury, Ashraful Islam Khan, Myron M. Levine, Wilbur H. Chen, Richelle C. Charles, Andrew S. Azman, Firdausi Qadri, (unknown), Jason B. Harris	4
6	Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023 2023 ·PubMed ·Susan L. Hills, Katherine A. Poehling, Wilbur H. Chen, J. Erin Staples	12
7	The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination 2022 ·npj Vaccines ·Johannes B. Goll, Aarti Jain, (unknown), (unknown), Rie Nakajima, Algis Jasinskas, Lynda Coughlan, (unknown), Casey E. Gelber, Saahir Khan, D. Huw Davies, Philip Meade, Daniel Stadlbauer, Shirin Strohmeier, Florian Krammer, Wilbur H. Chen, Philip L. Felgner	16
8	A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model 2021 ·PLoS neglected tropical diseases ·(unknown), (unknown), Mohamed Al‐Ibrahim, (unknown), Steven D. Dong, Christopher Gast, Laina D. Mercer, (unknown), Sharon M. Tennant, Wilbur H. Chen, Eugenio L. de Hostos, Robert K. M. Choy	7
9	National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines 2021 ·Eurosurveillance ·(unknown), Amanda J. Driscoll, (unknown), Wilbur H. Chen, Kathleen M. Neuzil, Justin R. Ortiz	21
10	Shigella-Controlled Human Infection Models: Current and Future Perspectives 2021 ·Current topics in microbiology and immunology ·Kristen A. Clarkson, Chad K. Porter, Kawsar R. Talaat, Melissa C. Kapulu, Wilbur H. Chen, Robert W. Frenck, A. Louis Bourgeois, Robert W. Kaminski, Laura B. Martin	3
11	The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region 2021 ·Vaccine ·Justin R. Ortiz, Joanie Robertson, (unknown), (unknown), Amanda J. Driscoll, (unknown), Wilbur H. Chen, Meagan C. Fitzpatrick, Samba O. Sow, Robin Biellik, Kathleen M. Neuzil	9
12	Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies 2019 ·Clinical Infectious Diseases ·Kawsar R. Talaat, A. Louis Bourgeois, Robert W. Frenck, Wilbur H. Chen, Calman A. MacLennan, Mark S. Riddle, Akamol E. Suvarnapunya, Jessica Brubaker, Karen L. Kotloff, Chad K. Porter	26
13	Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies 2018 ·mSphere ·Rie Nakajima, (unknown), Algis Jasinskas, Aarti Jain, (unknown), Joshua M. Obiero, Donald K. Milton, Wilbur H. Chen, Michael L. Grantham, Richard J. Webby, Florian Krammer, Darrick Carter, Philip L. Felgner, D. Huw Davies	39
14	Differences Between Pediatric and Adult T Cell Responses to In Vitro Staphylococcal Enterotoxin B Stimulation 2018 ·Frontiers in Immunology ·Mark E. Rudolph, Monica A. McArthur, (unknown), Laurence S. Magder, Wilbur H. Chen, Marcelo B. Sztein	23
15	In vitro – in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application 2017 ·Journal of Controlled Release ·(unknown), (unknown), Sam G. Raney, Priyanka Ghosh, Dana C. Hammell, Samer S. El‐Kamary, Wilbur H. Chen, (unknown), Hazem E. Hassan, Audra L. Stinchcomb	31
16	Impact of CD4+ T Cell Responses on Clinical Outcome following Oral Administration of Wild-Type Enterotoxigenic Escherichia coli in Humans 2017 ·PLoS neglected tropical diseases ·Monica A. McArthur, Wilbur H. Chen, Laurence S. Magder, Myron M. Levine, Marcelo B. Sztein	21
17	Tularemia vaccine: Safety, reactogenicity, “Take” skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain – A phase 2 randomized clinical Trial 2017 ·Vaccine ·Mark J. Mulligan, Jack T. Stapleton, Wendy A. Keitel, Sharon E. Frey, Wilbur H. Chen, Nadine Rouphael, Srilatha Edupuganti, Allison Beck, Patricia Winokur, Hana M. El Sahly, Shital M. Patel, Robert L. Atmar, Irene Graham, Edwin L. Anderson, Samer S. El‐Kamary, Marcela F. Pasetti, Marcelo B. Sztein, Heather Hill, Johannes B. Goll	20
18	Norovirus Vaccine against Experimental Human Norwalk Virus Illness 2011 ·New England Journal of Medicine ·Robert L. Atmar, David I. Bernstein, Clayton Harro, Mohamed Al‐Ibrahim, Wilbur H. Chen, Jennifer Ferreira, Mary K. Estes, David Y. Graham, Antone R. Opekun, Charles C. Richardson, Paul M. Mendelman	363
19	Vaccination in the elderly: an immunological perspective 2009 ·Trends in Immunology ·Wilbur H. Chen, (unknown), Rita B. Effros, Beatrix Grubeck‐Loebenstein, Robert Edelman, Marcelo B. Sztein	167
20	Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects 2007 ·Vaccine ·Robert B. Couch, Patricia Winokur, Rebecca C. Brady, Robert B. Belshe, Wilbur H. Chen, Thomas R. Cate, Bryndís Sigurðardóttir, (unknown), Irene Graham, Robert Edelman, (unknown), Diane Niño, Jose Capellan, Frederick L. Ruben	134

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact